The novel cardiac myosin inhibitor aficamten improved peak oxygen uptake in symptomatic obstructive hypertrophic cardiomyopathy (HCM), the pivotal SEQUOIA-HCM trial showed. At 24 weeks, the mean ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. This was a milestone year for sports cardiology ...

New research shows that exercise-based cardiac rehab offers real benefits for people with atrial fibrillation, reducing the risk of recurrence and improving mental well-being, highlighting the need ...

Oxygen saturation at 6 minutes improved with oxygen use, but perceived exertion scores (Borg dyspnea index) did not change.